Effect of Obesity on Prognosis After Early-Stage Breast Cancer

Department of Oncology, Odense University Hospital, Sdr Blvd 29, DK-5000 Odense, Denmark.
Journal of Clinical Oncology (Impact Factor: 18.43). 01/2011; 29(1):25-31. DOI: 10.1200/JCO.2010.29.7614
Source: PubMed


This study was performed to characterize the impact of obesity on the risk of breast cancer recurrence and death as a result of breast cancer or other causes in relation to adjuvant treatment.
Information on body mass index (BMI) at diagnosis was available for 18,967 (35%) of 53,816 women treated for early-stage breast cancer in Denmark between 1977 and 2006 with complete follow-up for first events (locoregional recurrences and distant metastases) up to 10 years and for death up to 30 years. Information was available on prognostic factors and adjuvant treatment for all patients. Univariate analyses were used to compare the associations of known prognostic factors and risks of recurrence or death according to BMI categories. Cox proportional hazards regression models were used to assess the influence of BMI after adjusting for other factors.
Patients with a BMI of 30 kg/m(2) or more were older and had more advanced disease at diagnosis compared with patients with a BMI below 25 kg/m(2) (P < .001). When data were adjusted for disease characteristics, the risk of developing distant metastases after 10 years was significantly increased by 46%, and the risk of dying as a result of breast cancer after 30 years was significantly increased by 38% for patients with a BMI of 30 kg/m(2) or more. BMI had no influence on the risk of locoregional recurrences. Both chemotherapy and endocrine therapy seemed to be less effective after 10 or more years for patients with BMIs greater than 30 kg/m(2).
Obesity is an independent prognostic factor for developing distant metastases and for death as a result of breast cancer; the effects of adjuvant therapy seem to be lost more rapidly in patients with breast cancer and obesity.

  • Source
    • "Our results revealed that obesity is associated with larger tumor size and higher tumor grade in both premenopausal and postmenopausal women. These findings are consistent with studies conducted on African American (Zhu et al., 2005), Danish (Ewertz et al., 2011), Iranian (Kaviani et al., 2013) and Asian women (Amadou et al., 2013). However, an inverse association between BMI and BC risk, with a 7% reduction in risk per 5 kg m "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Previous studies have suggested a link between obesity and breast cancer (BC). However, there is no universal consensus, especially in population based studies. Because only few studies have been conducted on African women, we aimed here to assess the relationship between BMI at time of diagnosis and the BC histopathological features among Tunisian patients according to menopausal status using a hospital-based prospective cohort study. Materials and methods: Clinical and pathological data were collected from 262 patients stratified on four groups according to their BMI. The relationship between BMI and histopathological features at diagnosis was analysed using univariate and multivariate analysis. Receiver-operating characteristic (ROC) curves were used to evaluate the performance of BMI in predicting of high tumor grade, in comparison to ki-67 index of proliferation. Results: Obesity was correlated with larger tumors, advanced grade and with ER-PR- Her2+ BC subtype. An association of BMI with tumor size and tumor grade was observed in both premenopausal and postmenopausal women. Additionally, a significant association between BMI and ER+, ER+PR+Her2+ and ER-PR-Her2+ status was revealed for premenopausal patients, while only ER+PR+Her2+ was associated with BMI for postmenopausal women. Finally, our results showed that compared to Ki67 proliferation index, BMI is a useful prognostic marker of high grade BC tumors. Conclusions: These data are the first to show that in Tunisia obese women suffering from BC have significantly larger tumors and advanced tumor grade and that higher BMI might influence tumor characteristics and behavior.
    Full-text · Article · Aug 2014 · Asian Pacific journal of cancer prevention: APJCP
  • Source
    • "More investigations are reporting that obesity is an independent risk factor for the development of breast cancer, and it has been associated with a poor outcome [45, 46]. Furthermore, obesity is an independent prognostic factor for developing distant metastases and the effects of adjuvant therapy seem to be lost more rapidly in patients with obesity [47]. Most studies report that obesity is correlated with breast cancer in postmenopausal women; however, study from population-based sample of 1,360 Australian women with breast cancer indicated that obesity is independently associated with poorer outcomes in premenopausal women, as it is in postmenopausal women [48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer survival has significantly improved over the past two decades. However, the diagnosis of breast cancer is lower and the mortality rate remains higher, in African American women (AA) compared to Caucasian-American women. The purpose of this investigation is to analyze postoperative events that may affect breast cancer survival. This is a retrospective analysis of prospectively collected data from The Brooklyn Hospital Center cancer registry from 1997 to 2010. Of the 1538 patients in the registry, 1226 are AA and 269 are Caucasian. The study was divided into two time periods, 1997-2004 (period A) and 2005-2010 (period B), in order to assess the effect of treatment outcomes on survival. During period A, 5-year survival probabilities of 75.37%, 74.53%, and 78.70% were seen among all patients, AA women and Caucasian women, respectively. These probabilities increased to 87.62%, 87.15% and 89.99% in period B. Improved survival in AA women may be attributed to the use of adjuvant chemotherapy, radiation, and hormonal therapy. Improved survival in Caucasian patients was attributed to the use of radiation therapy, as well as earlier detection resulting in more favorable tumor grades and pathological stages.
    Full-text · Article · Feb 2014
  • Source
    • "Cancer survivors with obesity have poorer cancerrelated outcomes than healthy weight patients including a higher number of second primary cancers and (Flegal et al. 2007; Daling et al. 2009) higher cancer recurrence (Flegal et al. 2007; Ewertz et al. 2011), cancer related mortality and overall mortality rates (Flegal et al. 2007; Sinicrope et al. 2010; Ewertz et al. 2011; Protani et al. 2010). Overweight and obese individuals with cancer are also at risk of worse shortterm outcomes like poor wound healing, increased rates of postoperative infections (Albino et al. 2009; Doyle et al. 2010), and poor response to treatment (Bastarrachea et al. 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity affects cancer risk and treatment outcomes. Preventing weight gain may prevent some cancers, improve cancer outcomes, reduce cancer recurrence and increase cancer-related survival. We performed a systematic review to identify strategies to prevent weight gain in individuals with or at risk for breast cancer. We included 2 studies from 27,879 citations. In premenopausal women at risk for breast cancer, a low fat diet prevented weight gain at 12 months. Among women with breast cancer, effective strategies to prevent weight gain included low-fat dietary counseling with self-management techniques. One trial reported on cancer outcomes, mortality and adverse events. Low-fat dietary counseling wilth self-management techniques lowers the risk breast cancer relapse by 24% compared with less intensive counseling with maintenance of nutritional status goal. There was no difference in overall mortality and no adverse events were observed. Limited evidence suggests that women with or at risk for breast cancer may successfully employ dietary and exercise strategies to prevent weight gain for at least one year. Low fat dietary counseling may improve cancer outcomes in women with breast cancer. Future studies should confirm these findings and evaluate the impact of weight gain prevention on cancer incidence, recurrence and survival.
    Full-text · Article · Dec 2013 · SpringerPlus
Show more